Interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer - retrospective study comparing surgery after 3 cycles or more of chemotherapy-Reference-Cited by-同舟云学术

Interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer - retrospective study comparing surgery after 3 cycles or more of chemotherapy

Published:2022-09 Issue:7 Volume:51 Page:102409
ISSN:2468-7847
Container-title:Journal of Gynecology Obstetrics and Human Reproduction
language:en
Short-container-title:Journal of Gynecology Obstetrics and Human Reproduction

Author:

Bacry Maureen Cohen^ORCID,Philippe Anne Cécile,Riethmuller Didier,Faucheron Jean Luc,Pomel Christophe

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference35 articles.

1. « Ovarian cancer statistics, 2018 »;Torre;CA Cancer J Clin,2018

2. « Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up »;Ledermann;Ann Oncol,2018

3. « Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma »;Griffiths;Natl Cancer Inst Monogr,1975

4. « Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis »;Bristow;J Clin Oncol,2002

5. « Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients »;Colombo;Eur J Surg Oncol,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-4 Cycles vs 6 Cycles NACT in Advanced Stage Epithelial Ovarian Cancer: Survival is not Determined by the Number of NACT Cycles;Chemotherapy;2023-12-19

2. Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival;Journal of Gynecologic Oncology;2023